stars 1 stars 2 stars 3

We develop innovative solutions based on the analysis of exhaled biomarkers as useful tools for the diagnosis, prognosis, and monitoring of various respiratory diseases, among which asthma stands out. We currently have the evernoa BASE device, which allows to measure airway inflammation by detecting Nitric Oxide through a simple and non-invasive test.

EVERSENS SL Questions

The EVERSENS SL annual revenue was $933000 in 2026.

Jorge Pascual Retuerta is the Chief Commercial Officer (CCO) of EVERSENS SL.

6 people are employed at EVERSENS SL.

EVERSENS SL is based in Noain, Navarre.

The NAICS codes for EVERSENS SL are [5417, 54171, 54, 541, 541713].

The SIC codes for EVERSENS SL are [87, 873].

Top EVERSENS SL Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users